AI dermatology imaging market seen reaching $2.9B by 2030

By AI, Created 4:47 PM UTC, May 18, 2026, /AGP/ – The Business Research Company says the AI dermatology imaging market will grow from $1.12 billion in 2025 to $2.9 billion by 2030 as skin cancer detection, teledermatology, and automated screening gain traction. North America led the market in 2025, while Asia-Pacific is expected to grow fastest through 2030.

Why it matters: - AI dermatology imaging is moving from a niche tool to a broader clinical workflow for skin cancer detection, diagnosis, and monitoring. - The market’s projected rise to $2.9 billion by 2030 signals growing demand for faster screening, more precise triage, and remote dermatology care. - The trend matters for clinics, hospitals, telehealth providers, and imaging software vendors as skin disease cases continue to rise.

What happened: - The Business Research Company published a 2026 market report on the global AI dermatology imaging market. - The report says the market will grow from $1.12 billion in 2025 to $1.36 billion in 2026. - The report projects the market will reach $2.9 billion by 2030. - The forecast implies a 21.0% CAGR from 2026 to 2030.

The details: - AI dermatology imaging uses machine learning to analyze skin images for diagnostic purposes. - The technology identifies, categorizes, and tracks skin conditions by reviewing patterns, textures, and color variations. - Automated image interpretation is designed to improve the speed and accuracy of detecting dermatological abnormalities. - Historical growth has been driven by the rising prevalence of skin disorders. - Other growth drivers include demand for more precise dermatological diagnoses, wider use of dermatoscopic and clinical imaging tools, expansion of dermatology clinics and hospital systems, and higher telehealth adoption. - Future growth is expected to come from stronger AI analytics, more cloud-based deployments, automated disease screening and triage, broader research use, teledermatology, remote patient monitoring, treatment monitoring, and workflow automation. - A free sample of the report is available here. - The full report is available here.

Between the lines: - Rising skin cancer incidence is a major demand driver because AI tools can spot subtle lesion changes that may be missed in routine review. - The Skin Cancer Foundation projected a 10.6% increase in new melanoma cases diagnosed in January 2026. - North America was the largest regional market in 2025. - Asia-Pacific is expected to post the fastest growth through the forecast period. - The regional split suggests mature adoption in the U.S. and Canada, with faster expansion likely in markets where digital dermatology is still scaling.

What’s next: - Market growth will likely track adoption of cloud-based AI tools, teledermatology, and remote monitoring platforms. - Continued progress in screening automation and workflow software could deepen use across hospitals and outpatient dermatology practices. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The bottom line: - AI dermatology imaging is entering a high-growth phase, powered by skin cancer screening needs and broader digital care adoption.